The Discounted Cash Flow (DCF) valuation of AtriCure Inc (ATRC) is (23.36) USD. With the latest stock price at 40.18 USD, the upside of AtriCure Inc based on DCF is -158.1%.
Based on the latest price of 40.18 USD and our DCF valuation, AtriCure Inc (ATRC) is a sell. selling AtriCure stocks now will result in a potential gain of 158.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.7% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (54.37) - (14.92) | (23.36) |
| Upside | -235.3% - -137.1% | -158.1% |